 CHAM, Switzerland, Dec. 03, 2020 GLOBE NEWSWIRE -- Bionovate Technologies Corp., traded on the Nasdaq OTC OTCPK:BIIO, plans to strategically invest in startups in Europe in the health and life care sector and focus its investments strategy towards on-demand healthcare services. The company is in the process of building a shortlist of startups which have the potential of disrupting their respective industry. 